FDA Approved: DOXYCYCLINE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves a supplemental application for doxycycline from Lupin Pharmaceuticals, Inc. to modify/expand an existing generic product approval (ANDA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris
• Chlamydial Infections
• Gonorrhea
• Lyme Disease
• Mycoplasma Pneumoniae Infections
• Respiratory Tract Infections
• Rickettsial Diseases
• Urinary Tract Infections

Drugs mentioned

• Doxycycline (Doxycycline)

Snippet

SUPPL AP for DOXYCYCLINE (DOXYCYCLINE)